Glucose control design using nonlinearity assessment techniques

AIChE Journal

Volumn 51, Issue 2, 2005, Pages 544-554

  Hernjak, Nicholas ^a   Doyle III, Francis J ^b  

^a University of Delaware   (United States)

^b University of California   (United States)

Author keywords

Diabetes; Nonlinear control; Nonlinearity characterization; Optimal control; Performance assessment

Indexed keywords

ALGORITHMS; CONTROL THEORY; GLUCOSE; HEALTH CARE; MEDICAL PROBLEMS; NONLINEAR SYSTEMS; OPTIMAL CONTROL SYSTEMS;

DIABETES; GLUCOSE CONTROL; LINEAR ALGORITHMS; NONLINEARITY ANALYSIS;

PATIENT TREATMENT;

GLUCOSE; INSULIN;

PROCESS CONTROL;

ALGORITHM; ARTICLE; CONTROL SYSTEM; DIABETES CONTROL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HUMAN; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN TREATMENT; MEASUREMENT; MODEL; NONLINEAR SYSTEM; PREDICTION;

EID: 14644403711     PISSN: 00011541     EISSN: None     Source Type: Journal    
DOI: 10.1002/aic.10326     Document Type: Article

References (29)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus. N. Engl. J. Med. 1993;329:977-986.
2. Wolpert HA. A clinician's perspective on some challenges in "closing the loop." Diabetes Technol. Ther. 2003;5:843-846.
3. MiniMed® CGMS®. Information available at: http://www.minimed. com/patientfam/pf_products_cgms_ov_completepic.shtml.
4. Glucowatch®. Information available at: http://www.glucowatch.com.
5. Disetronic. Information available at: http://www.disetronic-usa.com/ insulin-pumps.htm.
6. MiniMed® Paradigm® Insulin Pump. Information available at: http://www.minimed.com/patientfam/pf_ipt_paradigm_insulin_pump.shtml.
7. Lam Z-H, Hwang K-S, Lee J-Y, Chase JG, Wake GC. Active insulin infusion using optimal and derivative-weighted control. Med. Eng. Phys. 2002;24:663-672.
8. Panteleon AE, Loutseiko M, Steil GM, Rebrin K. A novel approach for closed loop control of meal induced carbohydrate intake. Proc. of Third Annual Diabetes Technology Meeting, San Francisco, CA; November 2003.
9. Parker RS, Doyle FJ III, Peppas NA. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans. Biomed. Eng. 1999;46:148-157.
10. ADICOL Project. Information available at: http://www.adicol.org/ project/posters/year_2002/dtm_2002_dms.pdf.
11. Ollerton RL. Application of optimal control theory to diabetes mellitus. Int. J. Control. 1989;50:2503-2522.
12. Fisher MEA. Semiclosed-loop algorithm for the control of blood glucose levels in diabetics. IEEE Trans. Biomed. Eng. 1991;38:57-61.
13. Parker RS, Gatzke EP, Doyle FJ III. Advanced Model Predictive Control (MPC) for Type I Diabetic Patient Blood Glucose Control. In: Proceedings of the American Control Conference. Chicago, IL; 2000: 3483-3487.
14. Hernjak N, Doyle FJ III. Correlation of process nonlinearity with closed-loop disturbance rejection. Ind. Eng. Chem. Res. 2003;42:4611-4619.
15. Desoer CA, Wang Y. Foundations of feedback theory for nonlinear systems. IEEE Trans. Circ. Syst. 1980;CAS-27:104-123.
16. Haber R. Nonlinearity test for dynamic processes. Proc. of the IFAC Identification and System Parameter Estimation Symposium. Elmsford, NY: Pergamon Press; 1985:409-414.
17. Ogunnaike BA, Pearson RK, Doyle FJ III. Chemical process characterization: With applications in the rational selection of control strategies. Proc. of the European Control Conference. Groningen, The Netherlands; 1993:1067-1071.
18. Guay M, McLellan P, Bacon D. Measurement of nonlinearity in chemical process control systems: The steady-state map. Can. J. Chem. Eng. 1995;73:868-882.
19. Nikolaou M, Hanagandi V. Nonlinear quantification and its application to nonlinear system identification. Chem. Eng. Commun. 1998;166:1-33.
20. Hahn J, Edgar TF. A gramian-based approach to nonlinearity quantification and model classification. Ind. Eng. Chem. Res. 2001;40:5724-5731.
21. Allgöwer F. Definition and computation of a nonlinearity measure. Proc. of the 3rd IFAC Nonlinear Control Systems Design Symposium. Elmsford, NY: Pergamon Press; 1995:279-284.
22. Helbig A, Marquardt W, Allgöwer F. Nonlinearity measures: Definition, computation and applications. J. Process Control. 2000;10:113-123.
23. Stack AJ, Doyle FJ III. The optimal control structure approach to measuring control-relevant nonlinearity. Comput. Chem. Eng. 1997; 21:998-1009.
24. Sorensen JT. A Physiologic Model of Glucose Metabolism in Man and Its Use to Design and Assess Improved Insulin Therapies for Diabetes. PhD Thesis. Dept. of Chemical Engineering, MIT, Cambridge, MA; 1985.
25. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man. J. Clin. Invest. 1981;68:1456-1467.
26. Furler SM, Kraegen EW, Smallwood RH, Chisolm DJ. Blood glucose control by intermittent loop closure in the basal mode: Computer simulation studies with a diabetic model. Diabetes Care. 1985;8:553-561.
27. Prett DM, Garcia CE. Fundamental Process Control. Boston, MA: Butterworth-Heinemann; 1998.
28. Allgöwer F, Badgwell TA, Qin JS, Rawlings JB, Wright SJ. Nonlinear predictive control and moving horizon estimation - An introductory overview. Advances in Control - Highlights of ECC '99. London: Springer-Verlag; 1999:391-449.
29. Lehmann ED, Deutsch T. A physiological model of glucose-insulin interaction in type I diabetes mellitus. J. Biomed. Eng. 1992;14:235-242.